SQUAWK/NEWS
Menu
Live News EARNINGS ARTICLE L impact

TransMedics Group Raises FY2026 Sales Guidance from $727.000M-$757.000M to $737.000M-$757.000M vs $732.700M Est

TransMedics Group (NASDAQ: TMDX ) raises FY2026 sales outlook from $727.000 million-$757.000 million to $737.000 million-$757.000 million vs $732.700 million estimate.

TMDX

TransMedics Group (NASDAQ: TMDX ) raises FY2026 sales outlook from $727.000 million-$757.000 million to $737.000 million-$757.000 million vs $732.700 million estimate.